COL1A2 and medulloblastoma: Although no mutations of COL1A2 have previously been reported for lymphomas, a potential pathogenetic role of these mutations is indicated from the finding that it is frequently epigenetically silenced in medulloblastoma and colorectal cancer [44,45].